The Greenville location houses primary manufacturing operations for the company’s biologic products sold in the United States. The company now offers a full line of synthetic bone grafts, human tissue products, traditional lumbar and cervical allograft, human demineralized bone matrix bone grafts and bone graft delivering accessories.
Related Articles on Orthopedic Devices:
Alphatec Spine Names Mark Francois Senior Director of Investor Relations
Stryker Pays $15M in Marketing Settlement
VG Innovations Releases Spine Device for Low Back Pain
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
